Sempresto
The Always There autoinjector, on your phone
https://wefunder.com/sempresto
Total raised on Wefunder: 512000
Total investors: 48
Quick facts
- Backed by $2.6M angel investment and Jefferson University Partnership
- FDA filing targeted within 18 months, with no clinical trials required
- Medtech leadership team trained at Harvard, MIT, Wharton, Johns Hopkins & UPenn Medicine
- 15 patents granted, 10 pending across phone-based autoinjector technology (US & ex-US)
- Targeting a $3B+ addressable market; 33M Americans living with food allergies
- World-class team with 3 IPOs and 30+ commercial product launches
- 85%+ projected gross margins at scale, priced below the current market average (not guaranteed)
- Innovative autoinjector designed to attach to a smartphone, compatible with 95% of phones